Stellar Biotechnologies Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,859.90
12,800.60
8,970.70
11,405.70
6,565.40
Total Accounts Receivable
177.70
52.20
157.60
85.80
1.30
Inventories
-
-
557.30
249.40
68.10
Other Current Assets
96.90
118.50
181.10
358.70
123.70
Total Current Assets
8,134.50
12,971.30
9,866.60
12,099.70
6,758.40
Net Property, Plant & Equipment
246.30
357.10
503.40
756.10
879.50
Total Investments and Advances
-
-
-
66.70
66.70
Intangible Assets
116.70
-
-
-
-
Other Assets
15.90
14.70
15.90
15.30
15.30
Total Assets
8,513.40
13,343.10
10,385.90
12,937.80
7,720.00
Accounts Payable
454.10
485.50
656.70
623.60
320.90
Other Current Liabilities
3,454.70
824.20
1,724.00
-
-
Total Current Liabilities
3,908.80
1,309.70
2,380.60
623.60
320.90
Other Liabilities
7,746.10
4,934.50
-
-
-
Total Liabilities
11,654.90
6,244.10
2,380.60
623.60
320.90
Common Equity (Total)
3,141.50
7,099.00
8,005.30
12,314.20
7,399.10
Total Shareholders' Equity
3,141.50
7,099.00
8,005.30
12,314.20
7,399.10
Total Equity
3,141.50
7,099.00
8,005.30
12,314.20
7,399.10
Liabilities & Shareholders' Equity
8,513.40
13,343.10
10,385.90
12,937.80
7,720.00
About Stellar Biotechnologies
View Profile
